DK0738273T3 - Monohydrat af (E) - 2' - (fluormethylen) -- cytidin - Google Patents

Monohydrat af (E) - 2' - (fluormethylen) -- cytidin

Info

Publication number
DK0738273T3
DK0738273T3 DK95907232T DK95907232T DK0738273T3 DK 0738273 T3 DK0738273 T3 DK 0738273T3 DK 95907232 T DK95907232 T DK 95907232T DK 95907232 T DK95907232 T DK 95907232T DK 0738273 T3 DK0738273 T3 DK 0738273T3
Authority
DK
Denmark
Prior art keywords
fluoromethylene
cytidine
monohydrate
deoxy
neoplastic
Prior art date
Application number
DK95907232T
Other languages
English (en)
Inventor
Richard E Donaldson
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of DK0738273T3 publication Critical patent/DK0738273T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK95907232T 1994-01-07 1994-12-13 Monohydrat af (E) - 2' - (fluormethylen) -- cytidin DK0738273T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17895294A 1994-01-07 1994-01-07
PCT/US1994/014648 WO1995018815A1 (en) 1994-01-07 1994-12-13 Monohydrate of (e)-2'-deoxy-2'-(fluoromethylene)cytidine

Publications (1)

Publication Number Publication Date
DK0738273T3 true DK0738273T3 (da) 2000-04-17

Family

ID=22654587

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95907232T DK0738273T3 (da) 1994-01-07 1994-12-13 Monohydrat af (E) - 2' - (fluormethylen) -- cytidin

Country Status (20)

Country Link
EP (1) EP0738273B1 (da)
JP (1) JPH09511227A (da)
KR (1) KR100330328B1 (da)
CN (1) CN1043231C (da)
AT (1) ATE186732T1 (da)
AU (1) AU684604B2 (da)
CA (1) CA2179987C (da)
DE (1) DE69421721T2 (da)
DK (1) DK0738273T3 (da)
ES (1) ES2141330T3 (da)
FI (1) FI114396B (da)
GR (1) GR3032614T3 (da)
HU (1) HU217849B (da)
IL (1) IL112242A (da)
MX (1) MX9500363A (da)
NO (1) NO306409B1 (da)
NZ (1) NZ279030A (da)
TW (1) TW397838B (da)
WO (1) WO1995018815A1 (da)
ZA (1) ZA9512B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100540046B1 (ko) 1997-11-12 2006-01-10 미쓰비시 가가꾸 가부시키가이샤 퓨린유도체 및 이를 유효성분으로 함유하는 의약
ES2206227T3 (es) 1999-05-11 2004-05-16 Mitsubishi Chemical Corporation Dihidrato de un derivado de purina, farmacos que lo contienen como ingrediente activo, e intermedio en su preparacion.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2002648C (en) * 1988-11-15 2000-02-29 James R. Mccarthy 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives
FI95269C (fi) * 1989-05-15 1996-01-10 Squibb Bristol Myers Co 2',3'-dideoksi-inosiinimonohydraatin, 2',3'-dideoksi-2',3'-didehydrot ymidiinimonohydraatin ja 2',3'-dideoksi-2'-fluori-inosiinihemihydraatin antiviraalisia, hyvin vesiliukoisia, stabiileja, kiteisiä suoloja
JPH0615557B2 (ja) * 1990-02-19 1994-03-02 ヤマサ醤油株式会社 2’―デオキシ―2’―メチリデンシチジンの2水和物結晶
EP0640092B1 (en) * 1992-05-12 1996-12-11 Merrell Pharmaceuticals Inc. A process for the preparation of ribonucleotide reductase inhibitors

Also Published As

Publication number Publication date
NZ279030A (en) 1997-05-26
HU217849B (hu) 2000-04-28
AU684604B2 (en) 1997-12-18
FI962769A (fi) 1996-07-05
ES2141330T3 (es) 2000-03-16
FI114396B (fi) 2004-10-15
CN1141045A (zh) 1997-01-22
MX9500363A (es) 1998-04-30
CA2179987C (en) 1999-01-19
NO306409B1 (no) 1999-11-01
DE69421721D1 (de) 1999-12-23
IL112242A (en) 2000-08-31
HUT75055A (en) 1997-03-28
AU1553295A (en) 1995-08-01
WO1995018815A1 (en) 1995-07-13
ATE186732T1 (de) 1999-12-15
EP0738273B1 (en) 1999-11-17
GR3032614T3 (en) 2000-05-31
DE69421721T2 (de) 2000-04-27
CA2179987A1 (en) 1995-07-13
KR100330328B1 (ko) 2002-12-05
IL112242A0 (en) 1995-03-30
JPH09511227A (ja) 1997-11-11
HU9601848D0 (en) 1996-09-30
EP0738273A1 (en) 1996-10-23
NO962848D0 (no) 1996-07-05
ZA9512B (en) 1995-09-11
FI962769A0 (fi) 1996-07-05
TW397838B (en) 2000-07-11
CN1043231C (zh) 1999-05-05
NO962848L (no) 1996-09-06

Similar Documents

Publication Publication Date Title
DK480284D0 (da) Sporstofmaerkede konjugater af metallothionein og maalsoegende, biologisk aktive molekyler
BRPI0411900A (pt) compostos antivirais e métodos
TR199701212T1 (xx) �drar� tutamama halinin tedavisi i�in alfa IL- agonistlerinin kullan�lmas�.
DK1021410T3 (da) Prostaglandinagonister og deres anvendelse til behandling af knogletilstande
BR9506667A (pt) Composto intermediário de cloro-pirimidina processo para a preparação do composto intermediário de cloro-pirimidina processo para a preparação de 2,5-diamino-4,6-dicloro-pirimidina processo para a preparação de 2,6-diamino-purinas e processo para a preparação de (1s,4s)-4-2-amino-6-(ciclo-propil-amino)-9h-purin-9-il¾-2-ciclo-penteno-1-metanol
ES2190447T3 (es) Pañal desechable.
DK0755249T3 (da) Anvendelse af Maillard-reaktionsinhibitor til behandling af amyloidose-baseret sygdom
ES2191292T3 (es) Compuestos antivirales poliaromaticos.
CA2002648A1 (en) 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives
DK0983271T3 (da) Carbocyklisk nucleosidhemisulfat og anvendelsen deraf i behandlingen af virusinfektioner
DK0750616T3 (da) Syreadditionssalte af 2,3,4,5-tetrahydro-1H-3-benzazapinforbindelser
DK0738273T3 (da) Monohydrat af (E) - 2' - (fluormethylen) -- cytidin
DK0550532T3 (da) Dextrinsulfater som anti-HIV-1-midler og præparat indeholdende disse
MY124071A (en) Treatment of viral disease in swine
ATE341293T1 (de) Kortikalknochenimplantat für wirbelfusion nach smith-robinson
DK0876146T3 (da) Nucleoside analoger i kombinationsterapi af herpes simplex infektioner
DK0459176T3 (da) Oligophosphater med antiviral virkning
BR0012380A (pt) 2-amino-benzoxazinonas para o tratamento de vìrus do herpes simples
DE69407180T2 (de) Fluoro-nukleosid-reinigung
ES2181160T3 (es) Derivados de 1,4-dihidropiridina y su utilizacion en terapia.
BR9804966A (pt) Brinquedo, painel de base e peça
LTIP1943A (en) Arylating agents, used in the treatment of cancerand disease caused by viral infection